Anya Borissova summarises a recent randomised placebo-controlled trial that evaluated ketamine metabolites, clinical response, and gamma power for major depression.
[read the full story...]
Thalia Eley and Gerome Breen explore a new systematic meta-review of predictors of antidepressant treatment outcome in depression, which looks at clinical and demographic variables, but also biomarkers including both genetic and neuroimaging data.
[read the full story...]
Marcus Munafo considers the findings of a systematic review of meta-analyses of observational studies, which looks at risk factors and peripheral biomarkers for psychotic disorders on the schizophrenia spectrum.
[read the full story...]
This review of salivary biomarkers for diagnosing periodontal disease only identified 4 studies at high risk of bias but suggests a small number of potential biomarkers. However the findings should be interpreted with caution.
[read the full story...]
Samei Huda reviews a meta-analysis of multivariate pattern recognition studies, which aims to detect neuroimaging biomarkers for schizophrenia.
[read the full story...]
Samei Huda steps into George Clooney’s shoes to discuss baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment.
[read the full story...]
Is it possible to work out which of two adolescents sitting before you complaining of unhappiness, which one will go home and sleep it off and which will go on to develop an episode of major depression? Has the biological revolution in psychiatry finally come to fruition with a useful biomarker for making treatment decisions? [read the full story…]
